{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T14:14:14Z","timestamp":1776003254664,"version":"3.50.1"},"publisher-location":"Singapore","reference-count":102,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811314254","type":"print"},{"value":"9789811314261","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-13-1426-1_22","type":"book-chapter","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T08:45:00Z","timestamp":1538037900000},"page":"275-285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Circular RNAs in Metabolic Diseases"],"prefix":"10.1007","author":[{"given":"Tianhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"issue":"11","key":"22_CR1","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1073\/pnas.73.11.3852","volume":"73","author":"HL Sanger","year":"1976","unstructured":"Sanger HL, Klotz G, Riesner D et al (1976) Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci USA 73(11):3852\u20133856","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"22_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K et al (2013) Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19(2):141\u2013157","journal-title":"RNA"},{"issue":"7441","key":"22_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A et al (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441):333\u2013338","journal-title":"Nature"},{"issue":"14","key":"22_CR4","doi-asserted-by":"publisher","first-page":"9461","DOI":"10.1093\/nar\/gku599","volume":"42","author":"ZA Afonina","year":"2014","unstructured":"Afonina ZA, Myasnikov AG, Shirokov VA et al (2014) Formation of circular polyribosomes on eukaryotic mRNA without cap-structure and poly(A)-tail: a cryo electron tomography study. Nucleic Acids Res 42(14):9461\u20139469","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"22_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.chom.2008.05.013","volume":"4","author":"CL Jopling","year":"2008","unstructured":"Jopling CL, Schutz S, Sarnow P (2008) Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4(1):77\u201385","journal-title":"Cell Host Microbe"},{"issue":"12","key":"22_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/genes7120116","volume":"7","author":"Yuhai Zhao","year":"2016","unstructured":"Zhao Y, Alexandrov PN, Jaber V et al (2016) Deficiency in the ubiquitin conjugating enzyme UBE2A in Alzheimer\u2019s Disease (AD) is linked to deficits in a natural circular miRNA-7 sponge (circRNA; ciRS-7). Genes (Basel) 7(12)","journal-title":"Genes"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"22572","DOI":"10.1038\/srep22572","volume":"6","author":"Q Liu","year":"2016","unstructured":"Liu Q, Zhang X, Hu X et al (2016) Circular RNA related to the chondrocyte ECM regulates MMP13 expression by functioning as a MiR-136 \u2018Sponge\u2019 in human cartilage degradation. Sci Rep 6:22572","journal-title":"Sci Rep"},{"issue":"17","key":"22_CR8","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1161\/CIRCULATIONAHA.117.029004","volume":"136","author":"K Shan","year":"2017","unstructured":"Shan K, Liu C, Liu BH et al (2017) Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in diabetes mellitus. Circulation 136(17):1629\u20131642","journal-title":"Circulation"},{"issue":"33","key":"22_CR9","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1093\/eurheartj\/ehv713","volume":"37","author":"K Wang","year":"2016","unstructured":"Wang K, Long B, Liu F et al (2016) A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. Eur Heart J 37(33):2602\u20132611","journal-title":"Eur Heart J"},{"issue":"4","key":"22_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrm3313","volume":"13","author":"V Rottiers","year":"2012","unstructured":"Rottiers V, Naar AM (2012) MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 13(4):239\u2013250","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7606","key":"22_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature18309","volume":"534","author":"RJ Perry","year":"2016","unstructured":"Perry RJ, Peng L, Barry NA et al (2016) Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature 534(7606):213\u2013217","journal-title":"Nature"},{"issue":"6","key":"22_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1001\/jama.2012.8402","volume":"308","author":"NH Afdhal","year":"2012","unstructured":"Afdhal NH (2012) Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both? JAMA 308(6):608\u2013616","journal-title":"JAMA"},{"issue":"2","key":"22_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/ATVBAHA.112.300144","volume":"33","author":"C Fernandez-Hernando","year":"2013","unstructured":"Fernandez-Hernando C, Ramirez CM, Goedeke L et al (2013) MicroRNAs in metabolic disease. Arterioscler Thromb Vasc Biol 33(2):178\u2013185","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S et al (2018) IDF diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271\u2013281","journal-title":"Diabetes Res Clin Pract"},{"key":"22_CR15","unstructured":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants (2016). The Lancet 387(10027):1513\u20131530."},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW et al (2018) Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 137:e67\u2013e492","journal-title":"Circulation"},{"issue":"10085","key":"22_CR17","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. The Lancet 389(10085):2239\u20132251","journal-title":"The Lancet"},{"issue":"3","key":"22_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1474-4422(14)70249-2","volume":"14","author":"PS Koekkoek","year":"2015","unstructured":"Koekkoek PS, Kappelle LJ, van den Berg E et al (2015) Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol 14(3):329\u2013340","journal-title":"Lancet Neurol"},{"issue":"2","key":"22_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.diabet.2014.09.004","volume":"41","author":"A Collier","year":"2015","unstructured":"Collier A, Ghosh S, Hair M et al (2015) Impact of socioeconomic status and gender on glycaemic control, cardiovascular risk factors and diabetes complications in type 1 and 2 diabetes: a population based analysis from a Scottish region. Diabetes Metab 41(2):145\u2013151","journal-title":"Diabetes Metab"},{"issue":"1","key":"22_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","volume":"17","author":"K Augustin","year":"2018","unstructured":"Augustin K, Khabbush A, Williams S et al (2018) Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol 17(1):84\u201393","journal-title":"Lancet Neurol"},{"issue":"2","key":"22_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21164\/pomjlifesci.141","volume":"62","author":"M Kaczorowska","year":"2016","unstructured":"Kaczorowska M, Ryterska K, Ossowski P et al (2016) Metabolic risk factors of coronary heart disease in relation to anthropometric measures in nonalcoholic fatty liver disease patients following dietary intervention. Pomeranian J Life Sci 62(2):8\u201314","journal-title":"Pomeranian J Life Sci"},{"key":"22_CR22","unstructured":"Organization WH Definition, Diagnosis and classification of diabetes mellitus and its complications part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation"},{"issue":"2","key":"22_CR23","first-page":"83","volume":"12","author":"N Ghaemi","year":"2018","unstructured":"Ghaemi N, Hasanabadi H, Ashrafzadeh F et al (2018) Peripheral neuropathy in children and adolescents with insulin-dependent diabetes Mellitus. Iran J Child Neurol 12(2):83\u201390","journal-title":"Iran J Child Neurol"},{"issue":"1","key":"22_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2337\/dci17-0052","volume":"41","author":"M Packer","year":"2018","unstructured":"Packer M (2018) Heart failure: the most important, preventable, and treatable cardiovascular complication of type 2 diabetes. Diabetes Care 41(1):11\u201313","journal-title":"Diabetes Care"},{"issue":"10","key":"22_CR25","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S2213-8587(17)30134-1","volume":"5","author":"VV Shanbhogue","year":"2017","unstructured":"Shanbhogue VV, Hansen S, Frost M et al (2017) Bone disease in diabetes: another manifestation of microvascular disease? Lancet Diabetes Endocrinol 5(10):827\u2013838","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9922","key":"22_CR26","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383(9922):1068\u20131083","journal-title":"Lancet"},{"key":"22_CR27","doi-asserted-by":"crossref","unstructured":"Kobayashi M, Zochodne DW (2018) Diabetic neuropathy and the sensory neuron: new aspects of pathogenesis and their treatment implications. J Diabetes Investig.","DOI":"10.1111\/jdi.12833"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.pathol.4.110807.092150","volume":"6","author":"YS Kanwar","year":"2011","unstructured":"Kanwar YS, Sun L, Xie P et al (2011) A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol 6:395\u2013423","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"22_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2337\/dc15-1585","volume":"39","author":"SS Schwartz","year":"2016","unstructured":"Schwartz SS, Epstein S, Corkey BE et al (2016) The time is right for a new classification system for diabetes: rationale and Implications of the beta-cell-centric classification schema. Diabetes Care 39(2):179\u2013186","journal-title":"Diabetes Care"},{"issue":"6","key":"22_CR30","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.cell.2012.02.010","volume":"148","author":"FM Ashcroft","year":"2012","unstructured":"Ashcroft FM, Rorsman P (2012) Diabetes mellitus and the beta cell: the last ten years. Cell 148(6):1160\u20131171","journal-title":"Cell"},{"issue":"9","key":"22_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.tem.2017.05.005","volume":"28","author":"SS Schwartz","year":"2017","unstructured":"Schwartz SS, Epstein S, Corkey BE et al (2017) A unified pathophysiological construct of diabetes and its complications. Trends Endocrinol Metab 28(9):645\u2013655","journal-title":"Trends Endocrinol Metab"},{"issue":"7014","key":"22_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature03076","volume":"432","author":"MN Poy","year":"2004","unstructured":"Poy MN, Eliasson L, Krutzfeldt J et\u00a0al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432(7014):226\u2013230","journal-title":"Nature"},{"issue":"3","key":"22_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1515\/BC.2008.026","volume":"389","author":"P Lovis","year":"2008","unstructured":"Lovis P, Gattesco S, Regazzi R (2008) Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol Chem 389(3):305\u2013312","journal-title":"Biol Chem"},{"issue":"52","key":"22_CR34","doi-asserted-by":"publisher","first-page":"21075","DOI":"10.1073\/pnas.1118922109","volume":"108","author":"RJA Frost","year":"2011","unstructured":"Frost RJA, Olson EN (2011) Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc. Natl Acad Sci 108(52):21075\u201321080","journal-title":"Proc. Natl Acad Sci"},{"issue":"15","key":"22_CR35","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1128\/MCB.01433-10","volume":"31","author":"TJ Pullen","year":"2011","unstructured":"Pullen TJ, da Silva Xavier G, Kelsey G et al (2011) miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol 31(15):3182\u20133194","journal-title":"Mol Cell Biol"},{"issue":"7353","key":"22_CR36","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nature10112","volume":"474","author":"M Trajkovski","year":"2011","unstructured":"Trajkovski M, Hausser J, Soutschek J et\u00a0al (2011) MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474(7353):649\u2013653","journal-title":"Nature"},{"issue":"22","key":"22_CR37","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1073\/pnas.1102281108","volume":"108","author":"A Davalos","year":"2011","unstructured":"Davalos A, Goedeke L, Smibert P et al (2011) miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci USA 108(22):9232\u20139237","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"22_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2013.04.022","volume":"375","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zhang L, Fan R et al (2013) The polymorphism in the let-7 targeted region of the Lin28 gene is associated with increased risk of type 2 diabetes mellitus. Mol Cell Endocrinol 375(1\u20132):53\u201357","journal-title":"Mol Cell Endocrinol"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2017.12.016","volume":"269","author":"DJ Lightell Jr","year":"2018","unstructured":"Lightell DJ Jr, Moss SC, Woods TC (2018) Upregulation of miR-221 and -222 in response to increased extracellular signal-regulated kinases 1\/2 activity exacerbates neointimal hyperplasia in diabetes mellitus. Atherosclerosis 269:71\u201378","journal-title":"Atherosclerosis"},{"issue":"1","key":"22_CR40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12012-015-9354-7","volume":"17","author":"Y Long","year":"2017","unstructured":"Long Y, Zhan Q, Yuan M et al (2017) The expression of microRNA-223 and FAM5C in cerebral infarction patients with diabetes mellitus. Cardiovasc Toxicol 17(1):42\u201348","journal-title":"Cardiovasc Toxicol"},{"issue":"18","key":"22_CR41","doi-asserted-by":"crossref","first-page":"26680","DOI":"10.18632\/oncotarget.8589","volume":"7","author":"H Xie","year":"2016","unstructured":"Xie H, Ren X, Xin S et al (2016) Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer. Oncotarget 7(18):26680\u201326691","journal-title":"Oncotarget"},{"issue":"4","key":"22_CR42","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.29270","volume":"66","author":"D Han","year":"2017","unstructured":"Han D, Li J, Wang H et al (2017) Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology 66(4):1151\u20131164","journal-title":"Hepatology"},{"issue":"4","key":"22_CR43","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.bbrc.2017.04.044","volume":"487","author":"B Zhou","year":"2017","unstructured":"Zhou B, Yu JW (2017) A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-beta1. Biochem Biophys Res Commun 487(4):769\u2013775","journal-title":"Biochem Biophys Res Commun"},{"key":"22_CR44","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev.cellbio.22.010305.104425","volume":"22","author":"JJ Heit","year":"2006","unstructured":"Heit JJ, Karnik SK, Kim SK (2006) Intrinsic regulators of pancreatic beta-cell proliferation. Annu Rev Cell Dev Biol 22:311\u2013338","journal-title":"Annu Rev Cell Dev Biol"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molmet.2018.01.010","volume":"9","author":"L Stoll","year":"2018","unstructured":"Stoll L, Sobel J, Rodriguez-Trejo A et al (2018) Circular RNAs as novel regulators of beta-cell functions in normal and disease conditions. Mol Metab 9:69\u201383","journal-title":"Mol Metab"},{"key":"22_CR46","doi-asserted-by":"publisher","first-page":"12453","DOI":"10.1038\/srep12453","volume":"5","author":"H Xu","year":"2015","unstructured":"Xu H, Guo S, Li W et al (2015) The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells. Sci Rep 5:12453","journal-title":"Sci Rep"},{"issue":"2","key":"22_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","volume":"6","author":"NL Henry","year":"2012","unstructured":"Henry NL, Hayes DF (2012) Cancer biomarkers. Mol Oncol 6(2):140\u2013146","journal-title":"Mol Oncol"},{"issue":"5","key":"22_CR48","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.beem.2016.08.001","volume":"30","author":"M Parrizas","year":"2016","unstructured":"Parrizas M, Novials A (2016) Circulating microRNAs as biomarkers for metabolic disease. Best Pract Res Clin Endocrinol Metab 30(5):591\u2013601","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"22_CR49","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tibs.2015.03.001","volume":"40","author":"S Guil","year":"2015","unstructured":"Guil S, Esteller M (2015) RNA-RNA interactions in gene regulation: the coding and noncoding players. Trends Biochem Sci 40(5):248\u2013256","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"22_CR50","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/gutjnl-2014-308737","volume":"66","author":"K Hur","year":"2017","unstructured":"Hur K, Toiyama Y, Okugawa Y et al (2017) Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer. Gut 66(4):654\u2013665","journal-title":"Gut"},{"issue":"7","key":"22_CR51","first-page":"516","volume":"38","author":"M Karakas","year":"2017","unstructured":"Karakas M, Schulte C, Appelbaum S et al (2017) Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study. Eur Heart J 38(7):516\u2013523","journal-title":"Eur Heart J"},{"issue":"1","key":"22_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0004563216649377","volume":"54","author":"L Sun","year":"2017","unstructured":"Sun L, Jiang R, Li J et\u00a0al (2017) MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer. Ann Clin Biochem 54(1):127\u2013133","journal-title":"Ann Clin Biochem"},{"issue":"8","key":"22_CR53","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/cr.2015.82","volume":"25","author":"Y Li","year":"2015","unstructured":"Li Y, Zheng Q, Bao C et al (2015) Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 25(8):981\u2013984","journal-title":"Cell Res"},{"issue":"10","key":"22_CR54","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1038\/bcj.2016.81","volume":"6","author":"A Bonizzato","year":"2016","unstructured":"Bonizzato A, Gaffo E, Te Kronnie G et al (2016) CircRNAs in hematopoiesis and hematological malignancies. Blood Cancer J 6(10):e483","journal-title":"Blood Cancer J"},{"issue":"1","key":"22_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1373\/clinchem.2014.230433","volume":"61","author":"JH Bahn","year":"2015","unstructured":"Bahn JH, Zhang Q, Li F et al (2015) The landscape of microRNA, Piwi-interacting RNA, and circular RNA in human saliva. Clin Chem 61(1):221\u2013230","journal-title":"Clin Chem"},{"issue":"3","key":"22_CR56","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/nar\/gkv1367","volume":"44","author":"Y Enuka","year":"2016","unstructured":"Enuka Y, Lauriola M, Feldman ME et al (2016) Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor. Nucleic Acids Res 44(3):1370\u20131383","journal-title":"Nucleic Acids Res"},{"issue":"47","key":"22_CR57","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.3748\/wjg.v23.i47.8345","volume":"23","author":"F Yang","year":"2017","unstructured":"Yang F, Liu D-Y, Guo J-T et al (2017) Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer. World J Gastroenterol 23(47):8345\u20138354","journal-title":"World J Gastroenterol"},{"key":"22_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cca.2017.01.025","volume":"466","author":"S Chen","year":"2017","unstructured":"Chen S, Li T, Zhao Q et al (2017) Using circular RNA hsa_circ_0000190 as a new biomarker in the diagnosis of gastric cancer. Clin Chim Acta 466:167\u2013171","journal-title":"Clin Chim Acta"},{"issue":"1","key":"22_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00432-016-2256-7","volume":"143","author":"L Xu","year":"2017","unstructured":"Xu L, Zhang M, Zheng X et al (2017) The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma. J Cancer Res Clin Oncol 143(1):17\u201327","journal-title":"J Cancer Res Clin Oncol"},{"key":"22_CR60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cca.2015.02.018","volume":"444","author":"P Li","year":"2015","unstructured":"Li P, Chen S, Chen H et al (2015) Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin Chim Acta 444:132\u2013136","journal-title":"Clin Chim Acta"},{"key":"22_CR61","doi-asserted-by":"publisher","first-page":"39918","DOI":"10.1038\/srep39918","volume":"7","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Li X, Gao C et al (2017) Peripheral blood circular RNA hsa_circ_0124644 can be used as a diagnostic biomarker of coronary artery disease. Sci Rep 7:39918","journal-title":"Sci Rep"},{"issue":"5","key":"22_CR62","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.celrep.2014.10.062","volume":"9","author":"JO Westholm","year":"2014","unstructured":"Westholm JO, Miura P, Olson S et al (2014) Genome-wide analysis of drosophila circular RNAs reveals their structural and sequence properties and age-dependent neural accumulation. Cell Rep 9(5):1966\u20131980","journal-title":"Cell Rep"},{"issue":"3","key":"22_CR63","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00592-016-0943-0","volume":"54","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Li X, Jian D et al (2017) Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus. Acta Diabetol 54(3):237\u2013245","journal-title":"Acta Diabetol"},{"issue":"6","key":"22_CR64","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1177\/1479164117722714","volume":"14","author":"X Li","year":"2017","unstructured":"Li X, Zhao Z, Jian D et al (2017) Hsa-circRNA11783-2 in peripheral blood is correlated with coronary artery disease and type 2 diabetes mellitus. Diab Vasc Dis Res 14(6):510\u2013515","journal-title":"Diab Vasc Dis Res"},{"key":"22_CR65","doi-asserted-by":"publisher","first-page":"40342","DOI":"10.1038\/srep40342","volume":"7","author":"CM Tang","year":"2017","unstructured":"Tang CM, Zhang M, Huang L et al (2017) CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts. Sci Rep 7:40342","journal-title":"Sci Rep"},{"issue":"12","key":"22_CR66","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.bbadis.2013.08.006","volume":"1832","author":"CM Sena","year":"2013","unstructured":"Sena CM, Pereira AM, Seica R (2013) Endothelial dysfunction\u00a0\u2013 a major mediator of diabetic vascular disease. Biochim Biophys Acta 1832(12):2216\u20132231","journal-title":"Biochim Biophys Acta"},{"issue":"14","key":"22_CR67","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1167\/iovs.17-22698","volume":"58","author":"SJ Zhang","year":"2017","unstructured":"Zhang SJ, Chen X, Li CP et al (2017) Identification and characterization of circular RNAs as a new class of putative biomarkers in diabetes retinopathy. Invest Ophthalmol Vis Sci 58(14):6500\u20136509","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1-2","key":"22_CR68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bbrc.2017.10.068","volume":"494","author":"J Chen","year":"2017","unstructured":"Chen J, Cui L, Yuan J et\u00a0al (2017) Circular RNA WDR77 target FGF-2 to regulate vascular smooth muscle cells proliferation and migration by sponging miR-124. Biochem Biophys Res Commun 494(1-2):126\u2013132","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"22_CR69","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/hep.24491","volume":"54","author":"N Bhala","year":"2011","unstructured":"Bhala N, Angulo P, van der Poorten D et al (2011) The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 54(4):1208\u20131216","journal-title":"Hepatology"},{"issue":"5","key":"22_CR70","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.dld.2010.01.016","volume":"42","author":"E Vanni","year":"2010","unstructured":"Vanni E, Bugianesi E, Kotronen A et al (2010) From the metabolic syndrome to NAFLD or vice versa? Dig Liver Dis 42(5):320\u2013330","journal-title":"Dig Liver Dis"},{"issue":"6","key":"22_CR71","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/jc.2015-1966","volume":"100","author":"P Portillo-Sanchez","year":"2015","unstructured":"Portillo-Sanchez P, Bril F, Maximos M et al (2015) High prevalence of nonalcoholic fatty liver disease in atients with type 2 diabetes Mellitus and normal plasma aminotransferase levels. J Clin Endocrinol Metab 100(6):2231\u20132238","journal-title":"J Clin Endocrinol Metab"},{"issue":"7384","key":"22_CR72","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia J, Elinav E, Jin C et al (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482(7384):179\u2013185","journal-title":"Nature"},{"issue":"4","key":"22_CR73","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ajg.2009.67","volume":"104","author":"LA Adams","year":"2009","unstructured":"Adams LA, Waters OR, Knuiman MW et al (2009) NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 104(4):861\u2013867","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"22_CR74","first-page":"384","volume":"5","author":"JM Pappachan","year":"2017","unstructured":"Pappachan JM, Babu S, Krishnan B et al (2017) Non-alcoholic fatty liver disease: a clinical update. J Clin Transl Hepatol 5(4):384\u2013393","journal-title":"J Clin Transl Hepatol"},{"issue":"4","key":"22_CR75","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.gtc.2016.07.003","volume":"45","author":"RM Carr","year":"2016","unstructured":"Carr RM, Oranu A, Khungar V (2016) Nonalcoholic fatty liver disease: pathophysiology and management. Gastroenterol Clin North Am 45(4):639\u2013652","journal-title":"Gastroenterol Clin North Am"},{"issue":"3","key":"22_CR76","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34(3):274\u2013285","journal-title":"Aliment Pharmacol Ther"},{"issue":"16","key":"22_CR77","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346(16):1221\u20131231","journal-title":"N Engl J Med"},{"issue":"2 Suppl 1","key":"22_CR78","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43(2 Suppl 1):S99\u2013s112","journal-title":"Hepatology"},{"issue":"2","key":"22_CR79","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","volume":"59","author":"AL Birkenfeld","year":"2014","unstructured":"Birkenfeld AL, Shulman GI (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59(2):713\u2013723","journal-title":"Hepatology"},{"issue":"22","key":"22_CR80","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA 313(22):2263\u20132273","journal-title":"JAMA"},{"issue":"8","key":"22_CR81","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1172\/JCI63539","volume":"122","author":"SH Hsu","year":"2012","unstructured":"Hsu SH, Wang B, Kota J et\u00a0al (2012) Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest 122(8):2871\u20132883","journal-title":"J Clin Invest"},{"issue":"10","key":"22_CR82","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.3390\/ijms17101620","volume":"17","author":"Teresa Auguet","year":"2016","unstructured":"Auguet T, Aragones G, Berlanga A et al (2016) miR33a\/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease. Int J Mol Sci 17(10)","journal-title":"International Journal of Molecular Sciences"},{"key":"22_CR83","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","volume":"424","author":"H Yamada","year":"2013","unstructured":"Yamada H, Suzuki K, Ichino N et al (2013) Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clin Chim Acta 424:99\u2013103","journal-title":"Clin Chim Acta"},{"key":"22_CR84","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1038\/ncomms8466","volume":"6","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zalzala M, Xu J et\u00a0al (2015) A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism. Nat Commun 6:7466","journal-title":"Nat Commun"},{"issue":"8","key":"22_CR85","doi-asserted-by":"publisher","first-page":"e72324","DOI":"10.1371\/journal.pone.0072324","volume":"8","author":"AM Miller","year":"2013","unstructured":"Miller AM, Gilchrist DS, Nijjar J et\u00a0al (2013) MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice. PLoS One 8(8):e72324","journal-title":"PLoS One"},{"issue":"22","key":"22_CR86","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1042\/CS20170987","volume":"131","author":"A Gastaldelli","year":"2017","unstructured":"Gastaldelli A (2017) Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD? Clin Sci (Lond) 131(22):2701\u20132704","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"22_CR87","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrd.2015.3","volume":"15","author":"G Musso","year":"2016","unstructured":"Musso G, Cassader M, Gambino R (2016) Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat Rev Drug Discov 15(4):249\u2013274","journal-title":"Nat Rev Drug Discov"},{"issue":"10126","key":"22_CR88","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/S0140-6736(18)30474-4","volume":"391","author":"SA Harrison","year":"2018","unstructured":"Harrison SA, Rinella ME, Abdelmalek MF et al (2018) NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet 391(10126):1174\u20131185","journal-title":"Lancet"},{"issue":"10019","key":"22_CR89","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","volume":"387","author":"MJ Armstrong","year":"2016","unstructured":"Armstrong MJ, Gaunt P, Aithal GP et al (2016) Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet 387(10019):679\u2013690","journal-title":"Lancet"},{"issue":"4","key":"22_CR90","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1159\/000487575","volume":"45","author":"J Guo","year":"2018","unstructured":"Guo J, Zhou Y, Cheng Y et al (2018) Metformin-induced changes of the coding transcriptome and non-coding RNAs in the livers of non-alcoholic fatty liver disease mice. Cell Physiol Biochem 45(4):1487\u20131505","journal-title":"Cell Physiol Biochem"},{"key":"22_CR91","first-page":"1","volume":"2017","author":"Xing-Ya Guo","year":"2017","unstructured":"Guo XY, He CX, Wang YQ et al (2017) Circular RNA profiling and bioinformatic modeling identify its regulatory role in hepatic steatosis. Biomed Res Int 2017:5936171","journal-title":"BioMed Research International"},{"key":"22_CR92","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pharmthera.2017.05.011","volume":"179","author":"N Tanaka","year":"2017","unstructured":"Tanaka N, Aoyama T, Kimura S et al (2017) Targeting nuclear receptors for the treatment of fatty liver disease. Pharmacol Ther 179:142\u2013157","journal-title":"Pharmacol Ther"},{"issue":"1","key":"22_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","volume":"27","author":"VT Samuel","year":"2018","unstructured":"Samuel VT, Shulman GI (2018) Nonalcoholic fatty liver disease as a Nexus of metabolic and hepatic diseases. Cell Metab 27(1):22\u201341","journal-title":"Cell Metab"},{"issue":"5","key":"22_CR94","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jhep.2016.11.020","volume":"66","author":"K Huang","year":"2017","unstructured":"Huang K, Du M, Tan X et al (2017) PARP1-mediated PPARalpha poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease. J Hepatol 66(5):962\u2013977","journal-title":"J Hepatol"},{"issue":"3","key":"22_CR95","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3748\/wjg.v24.i3.323","volume":"24","author":"XY Guo","year":"2018","unstructured":"Guo XY, Sun F, Chen JN et al (2018) circRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. World J Gastroenterol 24(3):323\u2013337","journal-title":"World J Gastroenterol"},{"key":"22_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3960197","volume":"2017","author":"Xing-Ya Guo","year":"2017","unstructured":"Guo XY, Chen JN, Sun F et al (2017) circRNA_0046367 Prevents hepatoxicity of lipid peroxidation: an inhibitory role against hepatic steatosis. Oxid Med Cell Longev 2017:3960197","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"22_CR97","doi-asserted-by":"crossref","unstructured":"Zhao R, Zhou J, Dong X et al (2018) Circular RNA expression alteration in exosomes from the brain extracellular space after traumatic brain injury in mice. J Neurotrauma","DOI":"10.1089\/neu.2017.5502"},{"issue":"2","key":"22_CR98","doi-asserted-by":"publisher","first-page":"e0148407","DOI":"10.1371\/journal.pone.0148407","volume":"11","author":"E Lasda","year":"2016","unstructured":"Lasda E, Parker R (2016) Circular RNAs co-precipitate with extracellular vesicles: a possible mechanism for circRNA clearance. PLoS One 11(2):e0148407","journal-title":"PLoS One"},{"issue":"3","key":"22_CR99","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/bcp.12987","volume":"82","author":"K Sridharan","year":"2016","unstructured":"Sridharan K, Gogtay NJ (2016) Therapeutic nucleic acids: current clinical status. Br J Clin Pharmacol 82(3):659\u2013672","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"22_CR100","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nbt0713-577","volume":"31","author":"A Bouchie","year":"2013","unstructured":"Bouchie A (2013) First microRNA mimic enters clinic. Nat Biotechnol 31(7):577","journal-title":"Nat Biotechnol"},{"issue":"10070","key":"22_CR101","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(16)31715-9","volume":"389","author":"MH Ree van der","year":"2017","unstructured":"van der Ree MH, de Vree JM, Stelma F et al (2017) Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial. Lancet 389(10070):709\u2013717","journal-title":"Lancet"},{"issue":"2","key":"22_CR102","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","volume":"35","author":"MS Beg","year":"2017","unstructured":"Beg MS, Brenner AJ, Sachdev J et\u00a0al (2017) Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest New Drugs 35(2):180\u2013188","journal-title":"Invest New Drugs"}],"container-title":["Advances in Experimental Medicine and Biology","Circular RNAs"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-1426-1_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T05:17:50Z","timestamp":1605071870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-1426-1_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811314254","9789811314261"],"references-count":102,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-1426-1_22","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}